DCM Shriram Fine Chemicals Limited
DCM Shriram Fine Chemicals Limited (DSFCL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
dsfcl.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 97 Cr | 93 Cr | 91 Cr |
| Operating expenses (approx.) | 97 Cr | 96 Cr | 86 Cr |
| EBITDA | 0.32 Cr | -3 Cr | 5 Cr |
| OPM % | 0.3% | -2.7% | 5.6% |
| Other income | 0.81 Cr | 0.74 Cr | 1 Cr |
| Interest | 0.24 Cr | 0.69 Cr | 0.44 Cr |
| Depreciation | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | -1 Cr | -5 Cr | 4 Cr |
| Tax % | -22.1% | 15.3% | 31.2% |
| Net profit | -1 Cr | -4 Cr | 3 Cr |
| EPS (₹) | ₹-0.17 | ₹-0.44 | ₹0.30 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 386 Cr | Sign in for TTM |
| Operating expenses (approx.) | 382 Cr | Sign in for TTM |
| EBITDA | 4 Cr | Sign in for TTM |
| OPM % | 0.9% | Sign in for TTM |
| Other income | 3 Cr | Sign in for TTM |
| Interest | 1 Cr | Sign in for TTM |
| Depreciation | 9 Cr | Sign in for TTM |
| Profit before tax | -3 Cr | Sign in for TTM |
| Tax % | -12.4% | Sign in for TTM |
| Net profit | -4 Cr | Sign in for TTM |
| EPS (₹) | ₹-0.41 | Sign in for TTM |
| Dividend payout % | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 17 Cr |
| Reserves | 194 Cr |
| Borrowings | 8 Cr |
| Other liabilities | 77 Cr |
| Total liabilities | 295 Cr |
| Fixed assets (net) | 98 Cr |
| CWIP | 0.23 Cr |
| Investments | 33 Cr |
| Inventories | 41 Cr |
| Trade receivables | 70 Cr |
| Cash & bank | 21 Cr |
| Other assets | 32 Cr |
| Total assets | 295 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 16 Cr |
| Cash from investing | 11 Cr |
| Cash from financing | -6 Cr |
| Net cash flow | 21 Cr |
| Free cash flow (OCF − Capex) | 14 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | -0.8% |
| ROE % | -1.7% |
| Debtor days | 66 |
| Inventory days | 66 |
| Days payable | 80 |
| Cash conversion cycle | 52 |
| Debt / equity | 0.04 |
| Current ratio | 2.76 |
| Net debt / EBITDA | -3.67 |
Compare with peers
Loading peers…